| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 Nov 25 | Sealbond | Common Stock | Conversion | Acquire C | Yes | No | 0 | 2,842,638 | 0.00 | 2,842,638 |
| 21 Nov 25 | Sealbond | Common Stock | Conversion | Acquire C | No | No | 0 | 21,610,950 | 0.00 | 21,822,333 |
| 21 Nov 25 | Sealbond | Series A-1 Preferred Stock Common Stock | Conversion | Dispose C | Yes | No | 0 | 284.264 | 0.00 | 0 |
| 21 Nov 25 | Sealbond | Series A Preferred Stock Common Stock | Conversion | Dispose C | No | No | 0 | 2,161.095 | 0.00 | 0 |
| 12 Mar 25 | CK Life Sciences Intl | Series A-1 Preferred Stock Common Stock | Grant | Acquire A | Yes | No | 7.01 | 284.264 | 1.99 k | 284.264 |